case_images: PMC5286473_01
case_images: PET CT before treatment. Stage II bulky Hodgkin lymphoma.
case_images: CRIHEM2017-9423205.001.jpg
case_images: PMC5286473_01_CRIHEM2017-9423205.001.jpg
case_images: fig1
case_images: Positron-emission tomography (PET) CT scan showed numerous lymphadenopathy lesions (axillary, pectoral) with a standard uptake value (SUV) max of 10.1 (Figure 1).
case_images: Follicle bulb onion, typical of Castleman disease. Stained section of lymph node biopsy, x100 magnification, HES coloration.
case_images: CRIHEM2017-9423205.002.jpg
case_images: PMC5286473_01_CRIHEM2017-9423205.002.jpg
case_images: fig2
case_images: A new anatomopathologic analysis led to the conclusion that a focal plasma cell variant of Castleman disease (Figures 2 and 3) coexisted in the same interfollicular area as CD30+ HL lesion (Figures 4, 5, and 6).
case_images: Plasmacytic cells labeled with MUM1 antibody. Section of lymph node biopsy, x400 magnification.
case_images: CRIHEM2017-9423205.003.jpg
case_images: PMC5286473_01_CRIHEM2017-9423205.003.jpg
case_images: fig3
case_images: A new anatomopathologic analysis led to the conclusion that a focal plasma cell variant of Castleman disease (Figures 2 and 3) coexisted in the same interfollicular area as CD30+ HL lesion (Figures 4, 5, and 6).
case_images: Plasmacytic cell and Hodgkin cell lymphoma. Section of lymph node biopsy, x100 magnification.
case_images: CRIHEM2017-9423205.004.jpg
case_images: PMC5286473_01_CRIHEM2017-9423205.004.jpg
case_images: fig4
case_images: A new anatomopathologic analysis led to the conclusion that a focal plasma cell variant of Castleman disease (Figures 2 and 3) coexisted in the same interfollicular area as CD30+ HL lesion (Figures 4, 5, and 6).
case_images: Hodgkin cells stained with anti-CD30 antibodies. Section of lymph node biopsy, x400 magnification.
case_images: CRIHEM2017-9423205.005.jpg
case_images: PMC5286473_01_CRIHEM2017-9423205.005.jpg
case_images: fig5
case_images: A new anatomopathologic analysis led to the conclusion that a focal plasma cell variant of Castleman disease (Figures 2 and 3) coexisted in the same interfollicular area as CD30+ HL lesion (Figures 4, 5, and 6).
case_images: Hodgkin cells. Section of lymph node biopsy, x400 magnification.
case_images: CRIHEM2017-9423205.006.jpg
case_images: PMC5286473_01_CRIHEM2017-9423205.006.jpg
case_images: fig6
case_images: A new anatomopathologic analysis led to the conclusion that a focal plasma cell variant of Castleman disease (Figures 2 and 3) coexisted in the same interfollicular area as CD30+ HL lesion (Figures 4, 5, and 6).
case_images: PET CT after treatment.
case_images: CRIHEM2017-9423205.007.jpg
case_images: PMC5286473_01_CRIHEM2017-9423205.007.jpg
case_images: fig7
case_images: The patient achieved complete remission, according to the Cheson criteria, assessed with PET CT, after 2 and 4 curative treatments (Figure 7).